Observer-Blinded Dose Escalating, Single Dose to Study Safety and Antimicrobial Efficacy of Gel vs. Placebo
Clinical trial NCT04192513 · TERMINATED
Trial details
- NCT number
- NCT04192513
- Sponsor
- DermBiont, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-20
- Primary completion
- 2020-06-30
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.